Japan's exports fell 0.1% in August, declining for a fourth consecutive month as higher U.S. tariffs crimped outbound trade. ...

Core Insights - GSK and Eli Lilly are expanding their manufacturing and operational capabilities in the United States [1] Group 1 - GSK has announced plans to enhance its manufacturing operations in America [1] - Eli Lilly is also set to increase its operational footprint in the U.S. [1]

In first public remarks since Trump removed her, Erika McEntarfer says she wanted to modernize federal statistics but the agency got caught in DOGE's crosshairs. ...

Major indexes are trading just under record highs. ...

Democrats are introducing a bill in the Senate that would bar central bank officials from simultaneously holding a separate presidentially appointed office. ...

Oracle, Silver Lake and Andreessen Horowitz are part of an investor consortium that will control an 80% stake. ...

Core Viewpoint - The new plant is set to open in 2028 and will support the production of the company's R2 SUV and smaller R3 crossover models [1] Group 1 - The plant's opening is scheduled for 2028 [1] - The facility will focus on manufacturing the R2 SUV model [1] - The plant will also support the production of the smaller R3 crossover model [1]

The SEC is prioritizing Trump's proposal to allow companies to report twice a year; many might still continue frequent reports ...

Weak economic growth and labor-market softness are on center stage for the central bank, overtaking inflation concerns. ...

Core Viewpoint - The company is committed to enhancing its domestic medicine production by establishing four new pharmaceutical manufacturing sites [1] Group 1 - The plan is part of the drugmaker's broader strategy to strengthen its manufacturing capabilities within the domestic market [1]